Chemical Component Summary

FormulaC14 H22 N2 O
Molecular Weight234.34
Isomeric SMILESCCN(CC)CC(=O)Nc1c(cccc1C)C

Chemical Details

Formal Charge0
Atom Count39
Chiral Atom Count0
Bond Count39
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB00281 
  • approved
  • vet_approved
DescriptionEver since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication [T583]. In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical procedures [F4349, L5930, L5948]. It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding sensations [F4349, L5930, L5948]. In doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others [F4349, L5930, L5948]. As a result, lidocaine is also considered a class Ib anti-arrhythmic agent [L5930, L5948, F4468]. Nevertheless, lidocaine's local anesthetic action sees its use in many medical situations or circumstances that may benefit from its action, including the treatment of premature ejaculation [A177625]. Regardless, lidocaine is currently available as a relatively non-expensive generic medication that is written for in millions of prescriptions internationally on a yearly basis. It is even included in the World Health Organization's List of Essential Medicines [L6055].
  • Lidocaine hydrochloride anhydrous
  • alpha-diethylamino-2,6-dimethylacetanilide
  • Lidocainum
  • 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
  • Lidocaine
Brand Names
  • CVS Health All Purpose Kit
  • ACME FIRST AID Contains 404 PIECES
  • Lidocaine Hydrochloride and Dextrose
  • Lidocare Arm, Neck, Leg
  • DermaNumb Tattoo Anesthetic Gel
IndicationLidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks [F4349, L5930].
  • Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
  • Agents that reduce seizure threshold
  • Amides
  • Amines
  • Analgesics and Anesthetics
  • S01HA07
  • D04AB01
  • R02AD02
  • C01BB01
  • S02DA01
CAS number137-58-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Sodium channel protein type 10 subunit alphaMEFPIGSLETNNFRRFTPESLVEIEKQIAAKQGTKKAREKHREQKDQEEK...unknowninhibitor
Sodium channel protein type 9 subunit alphaMAMLPPPGPQSFVHFTKQSLALIEQRIAERKSKEPKEEKKDDDEEAPKPS...unknowninhibitor
Sodium channel protein type 5 subunit alphaMANFLLPRGTSSFRRFTRESLAAIEKRMAEKQARGSTTLQESREGLPEEE...unknowninhibitor
Epidermal growth factor receptorMRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLS...unknownantagonist
Sodium channel protein type 4 subunit alphaMARPSLCTLVPLGPECLRPFTRESLAAIEQRAVEEEARLQRNKQMEIEEP...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference